De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing

Moving a cell culture process from the laboratory to commercial manufacturing requires more than increasing volume. Changes in equipment, process conditions, supply requirements, and quality controls can affect cell growth, productivity, product quality, cost, and speed to market. Experts from Thermo Fisher Scientific examine the key considerations involved in cell culture media manufacturing scale-up and share practical approaches for managing risk. Topics include building a transparent and reliable global supply strategy, evaluating the productivity and cost advantages of granular media formats, and responding to emerging regulatory and quality control requirements.

See how biopharmaceutical companies have addressed late-stage manufacturing challenges and advanced their processes toward commercial readiness.